Hysteroscopic Sterilization With Essure: Summary of the US Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance

被引：1
|
作者：
Steward, Rachel [1 ]
机构：
[1] FPA Womens Hlth, Long Beach, CA 90806 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2017年 / 129卷 / 04期
关键词：
D O I：
10.1097/AOG.0000000000001961
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：752 / 753
页数：3
相关论文
共 50 条
  • [21] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Fan, Min
    Chan, Adrienne Y. L.
    Yan, Vincent K. C.
    Tong, Xinning
    Lau, Lauren K. W.
    Wan, Eric Y. F.
    Tam, Eliza Y. T.
    Ip, Patrick
    Lum, Terry Y.
    Wong, Ian C. K.
    Li, X.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [22] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Min Fan
    Adrienne Y. L. Chan
    Vincent K. C. Yan
    Xinning Tong
    Lauren K. W. Lau
    Eric Y. F. Wan
    Eliza Y. T. Tam
    Patrick Ip
    Terry Y. Lum
    Ian C. K. Wong
    X. Li
    Orphanet Journal of Rare Diseases, 17
  • [23] Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
    Joshua D. Wallach
    Anita T. Luxkaranayagam
    Sanket S. Dhruva
    Jennifer E. Miller
    Joseph S. Ross
    BMC Medicine, 17
  • [24] Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for US Food and Drug Administration approval and postmarket surveillance of endoscopic devices
    Saleem, Nasir
    Ismail, Mohammad K.
    Tombazzi, Claudio R.
    Soin, Sarthak
    Dhruva, Sanket S.
    GASTROINTESTINAL ENDOSCOPY, 2021, 93 (01) : 231 - 238
  • [25] Highlights and implications of the 2019 proposed rule on sunscreens by the US Food and Drug Administration
    Wang, Steven Q.
    Lim, Henry W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (02) : 650 - 651
  • [26] US Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia
    Alvandi, Firoozeh
    Kwitkowski, Virginia E.
    Ko, Chia-Wen
    Rothmann, Mark D.
    Ricci, Stacey
    Saber, Haleh
    Ghosh, Debasis
    Brown, Janice
    Pfeiler, Erika
    Chikhale, Elsbeth
    Grillo, Joseph
    Bullock, Julie
    Kane, Robert
    Kaminskas, Edvardas
    Farrell, Ann T.
    Pazdur, Richard
    ONCOLOGIST, 2014, 19 (01): : 94 - 99
  • [27] Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
    DeMartino, Patrick C.
    Miljkovic, Milos D.
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2021, 181 (02) : 162 - 167
  • [28] Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
    Skydel, Joshua J.
    Luxkaranayagam, Anita T.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    JAMA NETWORK OPEN, 2019, 2 (05)
  • [29] The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience
    Mahabir, Chetaj A.
    DeFilippis, Ersilia M.
    Aggarwal, Sourabh
    Bath, Anandbir
    Qamar, Arman
    Patel, Nilay K.
    Goldsweig, Andrew M.
    Vaduganathan, Muthiah
    JOURNAL OF INVASIVE CARDIOLOGY, 2020, 32 (05): : E130 - E132
  • [30] Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System
    Chrischilles, Elizabeth A.
    Gagne, Joshua J.
    Fireman, Bruce
    Nelson, Jennifer
    Toh, Sengwee
    Shoaibi, Azadeh
    Reichman, Marsha E.
    Wang, Shirley
    Nguyen, Michael
    Zhang, Rongmei
    Izem, Rima
    Goulding, Margie R.
    Southworth, Mary Ross
    Graham, David J.
    Fuller, Candace
    Katcoff, Hannah
    Woodworth, Tiffany
    Rogers, Catherine
    Saliga, Ryan
    Lin, Nancy D.
    McMahill-Walraven, Cheryl N.
    Nair, Vinit P.
    Haynes, Kevin
    Carnahan, Ryan M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (03) : 263 - 271
12345